This study, published by Inter-Governmental Action Group against Money Laundering in West Africa (GIABA) is aimed at understanding the nature and magnitude of money laundering in West Africa as a result of counterfeiting pharmaceuticals. The study encourages countries to reorganise approaches in tracking, tracing and encoding legitimate products. Based on the findings of the study, one of the recommendations made is that law enforcement and regulatory officials involved in counterfeit pharmaceuticals should be adequately trained.
There are no comments for this item.